Entering text into the input field will update the search result below

Aeglea BioTherapeutics beats by $0.01, beats on revenue

Aug. 09, 2017 4:59 PM ETSpyre Therapeutics, Inc. (SYRE) StockBy: Niloofer Shaikh, SA News Editor
  • Aeglea BioTherapeutics (NASDAQ:AGLE): Q2 EPS of -$0.47 beats by $0.01.
  • Revenue of $1.48M (+8.0% Y/Y) beats by $0.19M.
  • Press Release

Recommended For You

More Trending News

About SYRE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SYRE--
Spyre Therapeutics, Inc.